Hoffmann-La Roche Limited, in consultation with Health Canada, has informed Canadian health care professionals of important safety information concerning RITUXAN® (rituximab).
From Health Canada:
Hoffmann-La Roche Limited, in consultation with Health Canada, has informed Canadian health care professionals of important safety information concerning RITUXAN® (rituximab).
For Health Professionals...
For the Public...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment